• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Biotechnology Portfolio

+ Add to Watchlist

FBIOX:US

175.92 USD 0.25 0.14%

As of 19:59:59 ET on 04/17/2014.

Snapshot for Fidelity Select Biotechnology Portfolio (FBIOX)

Year To Date: -3.20% 3-Month: -15.19% 3-Year: +31.42% 52-Week Range: 136.08 - 228.64
1-Month: -17.61% 1-Year: +27.83% 5-Year: +27.99% Beta vs MXWO: 1.02

Mutual Fund Chart for FBIOX

No chart data available.
  • FBIOX:US 175.92
  • 1M
  • 1Y
Interactive FBIOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBIOX

Fidelity Select Biotechnology Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-16-1985 Telephone: 1-800-544-6666
Managers: RAJIV KAUL
Web Site: www.fidelity.com

Fundamentals for FBIOX

NAV (on 2014-04-17) 175.92
Assets (M) (on 2014-03-31) 9,388.05
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBIOX

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) 0.23

Fees & Expenses for FBIOX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.56
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.79

Top Fund Holdings for FBIOX

Filing Date: 02/28/2014
Name Position Value % of Total
Gilead Sciences Inc 17,774,703 1,471,567,661 13.318%
Amgen Inc 8,067,562 1,000,539,039 9.055%
Biogen Idec Inc 2,107,367 717,937,790 6.497%
Intercept Pharmaceuticals Inc 1,315,567 540,040,254 4.887%
Alexion Pharmaceuticals Inc 2,931,080 518,214,944 4.690%
Celgene Corp 2,875,102 462,172,647 4.183%
Regeneron Pharmaceuticals Inc 1,279,549 425,450,043 3.850%
Vertex Pharmaceuticals Inc 4,075,800 329,569,188 2.983%
BioMarin Pharmaceutical Inc 2,294,144 185,825,664 1.682%
Pharmacyclics Inc 1,321,213 183,199,395 1.658%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil